JAMA Editor in Chief Kirsten Bibbins-Domingo reviews 4 JAMA trials presented at this year’s European Society of Cardiology (ESC) Congress on antihypertensive continuation before elective surgery, potassium supplementation after cardiac surgery, pulmonary vein isolation for symptomatic atrial fibrillation, and a triple-drug combination pill for resistant hypertension in Africa.

Correction: an earlier version of this podcast contained an error in the conclusion of the TIGHT K trial summary, which has been updated. Related Content:

JAMA Highlights From ESC 2024 10:04 Share

JAMA Clinical Reviews

Shownotes Transcript

JAMA Highlights From ESC 2024